The Future of Global Pharmaceutical Solutions



A global pharmaceutical platform encompassing critical aspects of drug development.

IP creation, clinical efficacy testing, regulatory approval, manufacturing, marketing, sales and distribution.

A pipeline filled with potential new medications, including a new treatment for diabetes, to be offered in China and the Asia-Pacific region.


The LeaderMed team’s expertise allows them to advance and obtain regulatory approvals for new drugs in China and the Asia-Pacific region faster than what can be secured in the U.S. and Europe.
In the China and Asia-Pacific markets our team members have led over 60 trials for innovative drugs; co-founded a CRO; led over 10 successful NDAs; and commercialized over $3 billion in global drug sales and medical devices, benefitting patients in over 50 countries.

What we believe

We are able to bring a product to market faster in China and the Asia-Pacific region because of our deep knowledge of the rapidly changing regulatory approval and intellectual property environments.
Dr. Joanne Jiang
CEO, LeaderMed Group
Play Video
Working with LeaderMed we have an opportunity to extend the global availability of two of our novel long-acting development products and to establish a presence in China in partnership with collaborators who have significant experience and deep knowledge of the Asian biopharmaceutical opportunity.
Dr. Phillip Frost, M.D.

What others are saying

A Live Webcast

The Founder and Chief Executive Officer of LeaderMed Group, Dr. Joanne Jiang will present at the 2022 Jefferies Healthcare Conference on Friday, 10 June 2022, at 8:30-8:55 AM in TRACK 1.

A live webcast of the presentation will be accessible at A replay of the presentation will be archived on LeaderMed’s website.

For more information on the conference or to schedule a one-on-one meeting with LeaderMed’s management, please contact Jefferies or Dr. Jenny Yuan via email at or phone at +1 (908) 552-9052.